Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#149 most reported symptom for this vaccine
Upper respiratory tract infection has been reported 210 times in association with Hib (Pedvaxhib) vaccination in VAERS. This represents 0.3% of all 60,298 reports for this vaccine.
Among these reports, 20 mentioned death (9.52%) and 56 involved hospitalization (26.7%).
Upper respiratory tract infection is the #149 most frequently reported symptom for Hib (Pedvaxhib) out of 2013 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 210 reports of Upper respiratory tract infection after Hib (Pedvaxhib) vaccination may seem alarming, but context is critical.
The 9.52% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.